DI

Dharmishthaben Indravadanbhai Trivedi

Active Director Director DIN 10324628
DIN 10324628 First appointment Sep 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Dharmishthaben Indravadanbhai Trivedi

Data last updated:

Dharmishthaben Indravadanbhai Trivedi is a Director at First Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals.

DIN 10324628
Primary Designation Director
Industry Chemicals
First Appointment 20 Sep 2023
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Sep 20232022Active

Board colleagues of Dharmishthaben Indravadanbhai Trivedi

Directorship timeline

Open interactive timeline →
First Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dharmishthaben Indravadanbhai Trivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dharmishthaben Indravadanbhai Trivedi

Dharmishthaben Indravadanbhai Trivedi currently holds 1 directorship: First Pharmaceuticals Private Limited (Director, since 20 Sep 2023).

Dharmishthaben Indravadanbhai Trivedi was first appointed on 20 Sep 2023 as Director at First Pharmaceuticals Private Limited.

The current boards of Dharmishthaben Indravadanbhai Trivedi's companies include Someshwar Komuravelli (First Pharmaceuticals Private Limited), Viraj Jayesh Shukla (First Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available